Baxter Corp Englewood v. Becton Dickinson Co

I. Executive Summary and Procedural Information

• Parties & Counsel:
  • Plaintiff: Baxter Corporation Englewood (Delaware)
  • Defendant: Becton, Dickinson and Company (New Jersey)
  • Plaintiff's Counsel: Sidley Austin LLP
• Case Identification: 3:26-cv-04562, S.D. Cal., 08/07/2026
• Venue Allegations: Venue is alleged to be proper as Defendant Becton, Dickinson and Company maintains a regular and established place of business within the Southern District of California, specifically a facility in San Diego.
• Core Dispute: Plaintiff alleges that Defendant's pharmacy automation and workflow management products infringe four patents related to systems and workstations for the safe and efficient preparation of medical doses.
• Technical Context: The technology concerns integrated workstations and software systems used in pharmacy settings to automate and document the process of compounding medications, thereby aiming to reduce errors and improve verification.
• Key Procedural History: The complaint alleges that Plaintiff provided Defendant with notice of U.S. Patent Nos. 10,045,912 and 10,347,374 via a letter dated March 11, 2020. For the two patents that issued after this date (U.S. Patent Nos. 11,620,803 and 12,045,757), the complaint alleges Defendant had knowledge from at least their respective issuance dates, in part because they are descendant from the '912 patent identified in the letter. The complaint also notes Defendant's acquisition of MedKeeper on July 28, 2022.

Case Timeline

Date	Event
2008-01-01	Plaintiff's DoseEdge product introduced to the market
2008-10-13	Priority Date for '374 Patent
2012-10-26	Priority Date for '912, '803, and '757 Patents
2018-08-14	'912 Patent Issued
2019-07-09	'374 Patent Issued
2020-03-11	Plaintiff sends notice letter to Defendant identifying '912 and '374 Patents
2020-11-24	Defendant files its own related patent application ('777 Application)
2022-07-28	Defendant acquires MedKeeper
2023-04-04	'803 Patent Issued
2024-07-23	'757 Patent Issued
2026-08-07	Complaint Filed

II. Technology and Patent(s)-in-Suit Analysis

U.S. Patent No. 10,045,912 - Work Station for Medical Dose Preparation System

The Invention Explained

• Problem Addressed: The patent's background describes the challenges in traditional pharmacy workflows for preparing medical doses, where manual processes are prone to error and verifying prepared doses is labor-intensive, often requiring a pharmacist to physically enter a sterile environment '912 Patent, col. 1:24-2:17
• The Patented Solution: The invention is a physical workstation that integrates an imaging device (e.g., a camera) and a specialized support platform to improve the documentation and verification of medication preparation '912 Patent, abstract The support platform includes a surface with physical grooves designed to hold and stabilize medication receptacles like syringes, preventing them from rolling or sliding during preparation and imaging '912 Patent, col. 6:63-7:10
• Technical Importance: This design aimed to improve the quality and efficiency of capturing documentation (e.g., images) for remote verification, enhancing both safety and workflow in sterile compounding environments '912 Patent, col. 3:7-21

Key Claims at a Glance

• The complaint asserts independent claims 1 and 27 Compl. ¶73
• Essential elements of independent claim 1 include:
  • A work station for use in a system for medical dose preparation management;
  • A support platform at least partially defining a medication-preparation staging region;
  • An outside face of the support platform adapted to support a medication receptacle, which includes a plurality of grooves;
  • A first portion of the grooves extending in a first direction (width) and a second portion extending in a second direction (length);
  • An imaging device physically supported relative to the base; and
  • An imaging field that encompasses at least a portion of the medication-preparation staging region.
• The complaint reserves the right to assert additional claims Compl. ¶73

U.S. Patent No. 10,347,374 - Medication Preparation System

The Invention Explained

• Problem Addressed: The patent identifies risks associated with manual or unguided medication compounding, where a pharmacy technician might deviate from the correct protocol, leading to errors that are difficult to catch, and where post-preparation review can be inefficient '374 Patent, col. 1:19-2:69
• The Patented Solution: The patent describes a computerized system that enforces a strict, step-by-step workflow for medication preparation. At each step, the system requires verification (e.g., scanning a barcode on a medication container) before allowing the user to proceed. If a verification step fails, the system is configured to display an error and "prevented from continuing to the next step" until the error is corrected or the dose is flagged as incomplete '374 Patent, col. 15:58-65 This creates a "hard stop" functionality.
• Technical Importance: This approach institutionalizes process control, making it more difficult for operators to make procedural errors or skip critical verification steps during compounding '374 Patent, abstract

Key Claims at a Glance

• The complaint asserts independent claims 16 and 21, as well as dependent claims 12-14 Compl. ¶89
• Essential elements of independent claim 16 include:
  • A medication compounding workstation system comprising a workstation with:
  • A communications interface to receive an electronic medication dose order;
  • A scanner to receive information from a source medication container;
  • An interactive graphical user interface to display a set of preparation steps to an operator; and
  • A digital camera to capture an image of the preparation.
  • The system is configured to verify, for each step, that a suitable source medication container is present.
  • If verification fails, the workstation is configured to display an error, require the operator to repeat the failed step, and prevent the operator from providing verification for the next step.
• The complaint reserves the right to assert additional claims Compl. ¶89

U.S. Patent No. 11,620,803 - Work Station for Medical Dose Preparation

Technology Synopsis

The '803 Patent describes a workstation apparatus that receives a dose-order workflow over a network and guides an operator through a sequence of steps. The system uses an integrated imaging device and an integrated scale to record digital image and weight data for verification at each step before proceeding to the next, and transmits the final data to a management system to enable dispensing Compl. ¶¶34, 36

Asserted Claims

Independent claims 1 and 12 Compl. ¶105

Accused Features

The complaint alleges that the Accused Systems provide guided workflows, use gravimetric and photo-documentation, and transmit data for remote verification, thereby infringing the '803 Patent Compl. ¶¶107-109

U.S. Patent No. 12,045,757 - Work Station for Medical Dose Preparation

Technology Synopsis

The '757 Patent claims a medical-dose preparation workstation that receives an ordered workflow, guides an operator through preparation steps, and uses integrated imaging, weighing, memory, and processing components to generate and store verification data. The patent also describes a physical workstation with a housing for the imaging device suspended over the staging region Compl. ¶¶42, 44

Asserted Claims

Independent claims 2 and 12 Compl. ¶121

Accused Features

The infringement allegations target the Accused Systems' use of guided workflows with integrated photo and weight capture for verification, as well as the physical structure of the workstation Compl. ¶¶123-125

III. The Accused Instrumentality

Product Identification

• The complaint names the BD Pyxis IV Prep, the BD Pyxis PharmacyKeeper, and MedKeeper as the "Accused Systems" Compl. ¶11

Functionality and Market Context

• The Accused Systems are described as a "technology assisted workflow and compliance management solution" that standardizes compounding processes to improve safety Compl. ¶¶53, 55
• Key alleged functionalities include "gravimetric verification, barcode automation, electronic documentation, and health information technology interoperability" Compl. ¶56 A provided screenshot from Defendant's marketing materials highlights features such as a "guided automated workflow," "real-time dose preparation error notifications via gravimetric analysis and workflow hard stops," and "automated NDC, lot, expiration and BUD capture" Compl. p. 13
• The complaint includes a photograph showing the Pyxis IV Prep workstation, which consists of a base with a scale and a suspended imaging device, visually aligning with the architecture described in the asserted patents Compl. p. 12
• The Pyxis PharmacyKeeper is described as a "customizable, cloud-based software for guided compounding workflow" Compl. ¶62 Defendant acquired the MedKeeper brand, which previously included this software, on July 28, 2022 Compl. ¶¶63-64

IV. Analysis of Infringement Allegations

U.S. Patent No. 10,045,912 Infringement Allegations

Claim Element (from Independent Claim 1)	Alleged Infringing Functionality	Complaint Citation	Patent Citation
A work station for use in a system for medical dose preparation management...	The Accused Systems include a workstation for preparing a medical dose.	¶57	col. 26:10-12
a support platform at least partially defining a medication-preparation staging region, and having a support surface...	The accused workstation includes a base that serves as a staging region.	¶57	col. 26:13-16
an outside face of the support platform... adapted to support at least a portion of a medication receptacle, the outside face including a plurality of grooves, wherein a first portion of the plurality of grooves extend across said first portion of the plurality of grooves in a first direction corresponding to a width of the support surface, while a second portion of the plurality of grooves extend across the first portion in a second direction corresponding to a length of the support surface...	The complaint does not provide sufficient detail for analysis of this element.		col. 26:17-25
an imaging device physically supported relative to the base, with an imaging field encompassing at least a portion of the medication-preparation staging region.	The accused workstation includes an imaging device suspended over the base, which captures an image of the medical dose being prepared on the staging region.	¶58; ¶60	col. 26:26-30

U.S. Patent No. 10,347,374 Infringement Allegations

Claim Element (from Independent Claim 16)	Alleged Infringing Functionality	Complaint Citation	Patent Citation
a communications interface configured to receive an electronic medication dose order for a patient-specific compounded medication dose over a network;	The Accused Systems are alleged to have "health information technology interoperability" and receive dose orders for guided workflows.	¶56; ¶91	col. 34:52-55
a scanner configured to receive medication information scanned from at least one source medication container;	The Accused Systems are alleged to include "barcode automation."	¶56	col. 34:56-58
an interactive graphical user interface configured to display, to a pharmacy operator, a set of steps for preparing the patient-specific compounded medication dose;	The Accused Systems are alleged to provide "guided workflow progression" and "step-by-step on-screen instructions."	¶91; ¶92	col. 34:59-63
a digital camera configured to capture a digital image of the pharmacy operator preparing the patient-specific compounded medication dose;	The Accused Systems are alleged to provide "automatic photo documentation" using an imaging device.	¶91; ¶58	col. 34:64-67
wherein, for each step...the medication compounding workstation is configured to verify...that a source medication container...is present...	The Accused Systems allegedly perform "dosage checks by an electronic scale" and use barcode automation for verification.	¶92; ¶56	col. 35:1-9
and if verification of the source medication container fails...the medication compounding workstation is configured to display an error in real-time...and require the pharmacy operator to repeat the failed step...and prevent the pharmacy operator from providing verification for a next step...	The Accused Systems are alleged to provide "real-time error notifications and hard stops."	¶91; p. 13	col. 35:10-18

Identified Points of Contention

• Scope Questions: A potential point of contention for the '912 Patent is whether the surface of the accused workstation includes the specific "plurality of grooves" extending in two different directions as claimed. The complaint's allegations focus heavily on the camera and software aspects of the system but provide no specific factual allegations regarding this physical surface structure, which is a required element of independent claim 1.
• Technical Questions: For the '374 Patent, the analysis may focus on the precise functionality of the accused system's "hard stops." A key question will be whether the system implements an absolute prevention of proceeding to the next step upon a verification failure, as the claim language "prevent the pharmacy operator from providing verification for the next step" suggests, or if it allows for potential overrides or alternative pathways not contemplated by the patent's strict workflow enforcement logic.

V. Key Claim Terms for Construction

The Term: "plurality of grooves" (from '912 Patent, Claim 1)

Context and Importance

This term defines a key physical structure of the workstation's support platform. Infringement of claim 1 of the '912 Patent directly depends on whether the accused product possesses a structure that meets this definition, as the complaint lacks specific evidence on this point.

Intrinsic Evidence for Interpretation

• Evidence for a Broader Interpretation: Practitioners may point to more general language in the specification, which refers to "a plurality of medication receptacle engagement features" '912 Patent, col. 6:40-41, to argue that "grooves" should not be limited to a specific shape or pattern but could encompass any surface features that engage a receptacle.
• Evidence for a Narrower Interpretation: The claim itself requires a "first portion" of grooves extending in one direction and a "second portion" in another, suggesting an intersecting or grid-like pattern. The specification further states these features can constrain a syringe in "at least two degrees of freedom" '912 Patent, 7:7-8, and Figures 11-14 depict a very specific recessed grid. This may support a narrower construction tied to this specific structure and function.

The Term: "prevent the pharmacy operator from providing verification for a next step" (from '374 Patent, Claim 16)

Context and Importance

This term is the functional core of the "hard stop" feature of the '374 Patent. The infringement analysis will likely turn on whether the accused system's error-handling protocol is coextensive with the strict "prevention" required by the claim.

Intrinsic Evidence for Interpretation

• Evidence for a Broader Interpretation: A party might argue that "prevent" should be understood in the context of the normal workflow, meaning the system's default action is to block progress, even if an authorized administrative override exists for exceptional circumstances.
• Evidence for a Narrower Interpretation: The specification states that if an error arises, "the dose order processing is prevented from continuing to the next step until the step is verified as being properly performed or until the dose order is flagged as being not completed due to an error" '374 Patent, col. 15:58-65 Practitioners may argue this language defines "prevent" as an absolute block with only two possible resolutions: success on retry or flagging the entire order as incomplete, excluding any other path forward.

VI. Other Allegations

Indirect Infringement

The complaint alleges that Defendant induces infringement by actively promoting the Accused Systems for their infringing uses Compl. ¶¶75, 91, 107, 123 Specific allegations point to Defendant's promotional materials, public demonstration videos, and courses on its "Learning Academy," which allegedly instruct and encourage users to employ the claimed features, such as gravimetric workflows, photo capture, and workflow-integrated hard stops Compl. ¶¶76-78 Compl. ¶¶92-94 Contributory infringement is also alleged on the basis that the components supplied by Defendant are specialized, essential parts of the claimed inventions, and not staple articles of commerce Compl. ¶¶80, 96, 112, 128

Willful Infringement

Willfulness allegations for the '912 and '374 Patents are based on alleged pre-suit knowledge stemming from a March 11, 2020 notice letter sent to Defendant's counsel Compl. ¶¶82, 98 For the '803 and '757 Patents, which issued after the notice letter, willfulness is based on alleged knowledge since at least their respective issue dates, with the complaint asserting Defendant was willfully blind to infringement given the patents' relationship to the '912 Patent that was the subject of the prior notice Compl. ¶¶114, 130

VII. Analyst's Conclusion: Key Questions for the Case

• A primary issue for the '912 patent will be one of structural presence: does the accused workstation's physical design include the specific, multi-directional "plurality of grooves" described in claim 1 for stabilizing receptacles, or will the infringement analysis hinge on a broader interpretation of "engagement features" for which the complaint provides more ambiguous support?
• A key evidentiary question for the '374 patent will be one of functional fidelity: do the accused system's "workflow hard stops" operate as an absolute barrier to procedural advancement upon failure, consistent with the patent's strict "prevent" limitation, or do they permit workarounds that would create a mismatch in technical operation?
• A central question for damages and willfulness will be the effect of notice: how will the court view the 2020 notice letter regarding the parent '912 patent when assessing Defendant's state of mind for the later-issuing '803 and '757 progeny patents, and can Plaintiff establish that this earlier notice created an affirmative duty for Defendant to assess and avoid infringement of subsequently issued, related patents?